Identification of Transduction Elements for Benzodiazepine Modulation of the GABAAReceptor: Three Residues Are Required for Allosteric Coupling
Authors:
Open Access
- 1 December 1999
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 19 (23) , 10213-10220
Abstract
Modulation of GABAAreceptors by benzodiazepines (BZDs) is believed to involve two distinct steps: a recognition step in which BZDs bind and a conformational transition step in which the affinity of the receptor for GABA changes. Previously, using γ2/α1chimeric subunits (χ), we demonstrated that although the N-terminal 167 γ2amino acid residues confer high-affinity BZD binding, other γ2domains couple BZD binding to potentiation of the GABA-mediated Cl−current (IGABA). To determine which γ2regions couple binding to potentiation, we generated χs with longer N-terminal γ2segments for voltage-clamp experiments inXenopusoocytes. Chimeras containing greater than the N-terminal 167 γ2residues showed incremental gains in maximal potentiation for diazepam enhancement ofIGABA. Residues in γ2199–236, γ2224–236 (pre-M1), and particularly γ2257–297 (M2 and surrounding loops) are important for BZD potentiation. For several positive BZD modulators tested, the same regions restored potentiation ofIGABA. In contrast, β-carboline inverse-agonism was unaltered in chimeric receptors, suggesting that structural determinants for positive and negative BZD allosteric modulation are different. Dissection of the γ2257–297 domain revealed that three residues in concert, γ2T281, γ2I282 (M2 channel vestibule), and γ2S291 (M2–M3 loop) are necessary to impart full BZD potentiation to chimeric receptors. Thus, these residues participate in coupling distant BZD-binding events to conformational changes in the GABAAreceptor. The location of these novel residues provides insight into the mechanisms underlying allosteric coupling for other members of the ligand-gated ion channel superfamily.Keywords
This publication has 24 references indexed in Scilit:
- Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptorsBritish Journal of Pharmacology, 1998
- The benzodiazepine binding site of GABAA receptorsTrends in Pharmacological Sciences, 1997
- Effects of Mutating Leucine to Threonine in the M2 Segment of α 1 and β 1 Subunits of GABA A α 1 β 1 ReceptorsThe Journal of Membrane Biology, 1996
- Identification of channel-lining residues in the M2 membrane-spanning segment of the GABA(A) receptor alpha1 subunit.Journal of General Physiology, 1996
- Potassium Currents Expressed from Drosophila and Mouse eag cDNAs in Xenopus OocytesNeuropharmacology, 1996
- Evolutionary history of the ligand-gated ion-channel superfamily of receptorsTrends in Neurosciences, 1995
- Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonistsNeuron, 1995
- Neurotransmitter-gated ion channels as unconventional allosteric proteinsCurrent Opinion in Structural Biology, 1994
- Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAsNeuron, 1992
- On the nature of allosteric transitions: A plausible modelJournal of Molecular Biology, 1965